{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T22:39:36Z","timestamp":1771540776709,"version":"3.50.1"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2017,4,13]],"date-time":"2017-04-13T00:00:00Z","timestamp":1492041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0175809","type":"journal-article","created":{"date-parts":[[2017,4,13]],"date-time":"2017-04-13T14:12:35Z","timestamp":1492092755000},"page":"e0175809","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Relation between macular morphology and treatment frequency during twelve months with ranibizumab for diabetic macular edema"],"prefix":"10.1371","volume":"12","author":[{"given":"Yuki","family":"Mori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0314-8807","authenticated-orcid":true,"given":"Tomoaki","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Suzuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Yoshitake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Dodo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Yoshitake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Miwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akitaka","family":"Tsujikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,4,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"JW Yau","year":"2012","journal-title":"Diabetes Care"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMra1005073","article-title":"Diabetic retinopathy","volume":"366","author":"DA Antonetti","year":"2012","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders","volume":"331","author":"LP Aiello","year":"1994","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0002-9394(01)01269-7","article-title":"Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema","volume":"133","author":"H Funatsu","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2337\/db11-1367","article-title":"Protein kinase cbeta phosphorylates occludin regulating tight junction trafficking in vascular endothelial growth factor-induced permeability in vivo","volume":"61","author":"T Murakami","year":"2012","journal-title":"Diabetes"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.ophtha.2005.06.007","article-title":"A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema","volume":"112","author":"ET Cunningham Jr.","year":"2005","journal-title":"Ophthalmology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ophtha.2010.02.031","article-title":"Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema","volume":"117","author":"MJ Elman","year":"2010","journal-title":"Ophthalmology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ophtha.2011.01.031","article-title":"The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema","volume":"118","author":"P Mitchell","year":"2011","journal-title":"Ophthalmology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.ophtha.2014.05.006","article-title":"Intravitreal aflibercept for diabetic macular edema","volume":"121","author":"JF Korobelnik","year":"2014","journal-title":"Ophthalmology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ophtha.2011.12.039","article-title":"Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE","volume":"119","author":"QD Nguyen","year":"2012","journal-title":"Ophthalmology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1136\/bjophthalmol-2015-307249","article-title":"Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN study","volume":"100","author":"C Prunte","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ophtha.2014.08.047","article-title":"Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results","volume":"122","author":"MJ Elman","year":"2015","journal-title":"Ophthalmology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.ophtha.2013.11.041","article-title":"Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE extension study","volume":"121","author":"U Schmidt-Erfurth","year":"2014","journal-title":"Ophthalmology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/archophthalmol.2012.1043","article-title":"Long-term effects of ranibizumab on diabetic retinopathy severity and progression","volume":"130","author":"MS Ip","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.ophtha.2014.03.021","article-title":"Neutralization of vascular endothelial growth factor slows progression of retinal nonperfusion in patients with diabetic macular edema","volume":"121","author":"PA Campochiaro","year":"2014","journal-title":"Ophthalmology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1001\/jamaophthalmol.2015.4070","article-title":"Systemic safety of prolonged monthly anti-vascular endothelial growth factor therapy for diabetic macular edema: a systematic review and meta-analysis","volume":"134","author":"RL Avery","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1016\/j.ophtha.2012.09.015","article-title":"Clinical applications of cost analysis of diabetic macular edema treatments","volume":"119","author":"WE Smiddy","year":"2012","journal-title":"Ophthalmology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.ophtha.2013.02.002","article-title":"Cost-effectiveness of various interventions for newly diagnosed diabetic macular edema","volume":"120","author":"JD Stein","year":"2013","journal-title":"Ophthalmology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.ophtha.2015.03.032","article-title":"The cost-effectiveness of ranibizumab for the treatment of diabetic macular edema","volume":"122","author":"GC Brown","year":"2015","journal-title":"Ophthalmology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.ophtha.2016.04.004","article-title":"Predictors of diabetic macular edema treatment frequency with ranibizumab during the open-label extension of the RIDE and RISE Trials","volume":"123","author":"CC Wykoff","year":"2016","journal-title":"Ophthalmology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"8154","DOI":"10.1167\/iovs.12-10290","article-title":"Retinal Thickness in people with diabetes and minimal or no diabetic retinopathy: Heidelberg Spectralis Optical Coherence Tomography","volume":"53","author":"KV Chalam","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ajo.2010.08.022","article-title":"Association of pathomorphology, photoreceptor status, and retinal thickness with visual acuity in diabetic retinopathy","volume":"151","author":"T Murakami","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1167\/iovs.13-13417","article-title":"Integrative understanding of macular morphologic patterns in diabetic retinopathy based on self-organizing map","volume":"55","author":"T Murakami","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ophtha.2015.09.032","article-title":"Effect of vitreomacular adhesion on treatment outcomes in the Ranibizumab for Edema of the Macula in Diabetes (READ-3) Study","volume":"123","author":"MA Sadiq","year":"2016","journal-title":"Ophthalmology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1167\/iovs.11-9231","article-title":"Optical coherence tomographic reflectivity of photoreceptors beneath cystoid spaces in diabetic macular edema","volume":"53","author":"T Murakami","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1001\/jamaophthalmol.2014.2350","article-title":"Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema","volume":"132","author":"JK Sun","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.ophtha.2015.02.036","article-title":"Predictors of functional and anatomic outcomes in patients with diabetic macular edema treated with ranibizumab","volume":"122","author":"R Sophie","year":"2015","journal-title":"Ophthalmology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/IAE.0000000000000059","article-title":"Spectral domain optical coherence tomography predictors of visual outcome in diabetic cystoid macular edema after bevacizumab injection","volume":"34","author":"A Al Faran","year":"2014","journal-title":"Retina"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/IAE.0b013e31826b6763","article-title":"Visual outcome after intravitreal bevacizumab depends on the optical coherence tomographic patterns of patients with diffuse diabetic macular edema","volume":"33","author":"M Shimura","year":"2013","journal-title":"Retina"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ophtha.2016.09.021","article-title":"Randomized trial of treat and extend ranibizumab with and without navigated laser for diabetic macular edema: TREX-DME 1 Year Outcomes","volume":"124","author":"JF Payne","year":"2017","journal-title":"Ophthalmology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10384-016-0458-9","article-title":"Reduction in the frequency of intravitreal bevacizumab administrations achieved by posterior subtenon injection of triamcinolone acetonide in patients with diffuse diabetic macular edema","volume":"60","author":"M Shimura","year":"2016","journal-title":"Jpn J Ophthalmol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/archophthalmol.2012.1107","article-title":"Factors associated with changes in visual acuity and central subfield thickness at 1 year after treatment for diabetic macular edema with ranibizumab","volume":"130","author":"SB Bressler","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1097\/IAE.0000000000000617","article-title":"Ranibizumab plus prompt or deferred laser for diabetic macular edema in eyes with vitrectomy before anti-vascular endothelial growth factor therapy","volume":"35","author":"SB Bressler","year":"2015","journal-title":"Retina"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.ophtha.2009.10.040","article-title":"Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction","volume":"117","author":"JA Haller","year":"2010","journal-title":"Ophthalmology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1177\/43.4.7534783","article-title":"Ultrastructural localization of vascular permeability factor\/vascular endothelial growth factor (VPF\/VEGF) to the abluminal plasma membrane and vesiculovacuolar organelles of tumor microvascular endothelium","volume":"43","author":"H Qu","year":"1995","journal-title":"J Histochem Cytochem"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/nature07424","article-title":"A role for VEGF as a negative regulator of pericyte function and vessel maturation","volume":"456","author":"JI Greenberg","year":"2008","journal-title":"Nature"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0002-9440(10)65044-4","article-title":"Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1)","volume":"156","author":"K Miyamoto","year":"2000","journal-title":"Am J Pathol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nm877","article-title":"Leukocytes mediate retinal vascular remodeling during development and vaso-obliteration in disease","volume":"9","author":"S Ishida","year":"2003","journal-title":"Nat Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1167\/iovs.13-12382","article-title":"Correlation between reflectivity of subretinal fluid in OCT images and concentration of intravitreal VEGF in eyes with diabetic macular edema","volume":"54","author":"S Sonoda","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"10836","DOI":"10.1073\/pnas.96.19.10836","article-title":"Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition","volume":"96","author":"K Miyamoto","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.ophtha.2014.10.028","article-title":"Effects of intravitreal ranibizumab on retinal hard exudate in diabetic macular edema: findings from the RIDE and RISE phase III clinical trials","volume":"122","author":"A Domalpally","year":"2015","journal-title":"Ophthalmology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ophtha.2010.03.035","article-title":"Foveal cystoid spaces are associated with enlarged foveal avascular zone and microaneurysms in diabetic macular edema","volume":"118","author":"T Murakami","year":"2011","journal-title":"Ophthalmology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ophtha.2006.06.052","article-title":"Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema","volume":"114","author":"DJ Browning","year":"2007","journal-title":"Ophthalmology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"39161","DOI":"10.1038\/srep39161","article-title":"Restoration of foveal photoreceptors after intravitreal ranibizumab injections for diabetic macular edema","volume":"6","author":"Y Mori","year":"2016","journal-title":"Sci Rep"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1016\/j.ophtha.2016.07.010","article-title":"Optical coherence tomography angiography of dme and its association with Anti-VEGF treatment response","volume":"123","author":"J Lee","year":"2016","journal-title":"Ophthalmology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0175809","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T10:24:22Z","timestamp":1540203862000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0175809"}},"subtitle":[],"editor":[{"given":"Keisuke","family":"Mori","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,4,13]]},"references-count":45,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,4,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0175809","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,13]]}}}